INTRODUCTION: The individual patient prognosis after radical surgery for Non-small cell lung cancer (NSCLC) of left upper lobe remains still unclear. The purpose of this study is to evaluate the predictive value of elevated white blood cell count in peripheral blood as early indicator of postoperative NSCLC prognosis. METHODS: A retrospective statistical analysis was performed studying patients subject to radical treatment of left upper lobe NSCLC in period of fi ve years with subsequent one to three-year monitoring of morbidity and mortality of the patient population. The statistical ROC (Receiver Operating Characteristic) analysis of the WBC count in peripheral blood third day after the operation was used to evaluate the relationship with overall survival, with respect to patients surviving for at least 24 months. RESULTS: Based on the results of the ROC analysis with a total area under the curve (AUC) of 0.67, it is possible to confi rm that the WBC count established third day after the operation allows us to classify patients into groups according to the 24-month overall survival. CONCLUSION: Our fi ndings confi rm the potential of using WBC count to improve current protocols to establish postoperative prognosis for NSCLC of the upper left lobe (Tab. 2, Fig. 1, Ref. 11) . Text in PDF www.elis.sk. KEY WORDS: postoperative white blood cells, peripheral blood, radical surgical treatment, left upper lobe, nonsmall cell lung cancer, survival-single center results. Fig. 1. Overall survival of patients after the operation in relation to the WBC count 3 days after the operation.
Introduction
Non-small cell lung carcinoma (NSCLC) is, despite all the extensive efforts to treat it, one of the most frequent cause of cancer mortality globally. The left upper lobe is characterized by a unique lymph drainage system and early metastases in the lymph nodes in the aortopulmonary region that is arduous to detect pre-operationally. In patients with aortopulmonary area nodal involvement after radical surgery, it is diffi cult to objectively predict the recurrence of the disease or the prognosis. No marker has yet been found able to indicate the probability of cancer recurrence or to identify risk sub-groups of patients in individual clinical stages. Various molecular genetic markers have been studied, but using such markers is very costly. This is why efforts are made to fi nd a marker that would be a part of the routine perioperative tests and would not add to the costs of medical facilities for treating one patient. The current trend is to look at tumour-associated immunopathological mechanisms leading to a sterile infl ammatory response in order to evaluate the prognosis of solid tumours. These processes cause changes in the infl ammatory markers count, specifi cally WBC (White blood cells) and CRP (C-reactive protein) level in peripheral blood. A few studies have focused on evaluating preoperative WBC and CRP levels as a prognostic marker (1, 2) . The results show the comparison of neutrophil and leukocyte ratio to be one of the most promising predictors (3, 4) . An analysis of postoperative changes in the concentration of acute-phase serum proteins and WBC count could be infl uenced by the degree of operative stress. Empirically, WBC counts return to normal 48-72 hours after the operation. A WBC count of 10,00x10 9 in peripheral blood is generally accepted as the upper limit of the normal range (5) . Evaluation of the relationship between WBC count and overall survival after radical surgery of left upper lobe NSCLC has not been published to our knowledge. This study investigates the possibility of using postoperative WBC count on the third day after the operation to predict the recurrence of cancer after radical surgical treatment.
Methods
A retrospective statistical analysis was performed, studying patients who were subject to radical surgical treatment of left upper lobe NSCLC at the First departement of surgery in Brno, Czech Republic, in a fi ve-year period (from 2011 to 2015) with subsequent one to three-year monitoring of morbidity and mortality of the patient population. Peripheral WBC counts were obtained for patients on postoperative day 3. The patient population was evaluated according to American Society of Anesthesiologist score (ASA), representing stage ASA II, i.e. patients with various extent of chronic disease lacking functional limitation. Criteria for inclusion were: WBC count under 10,00 x 10 9 and CRP level below 5 mg/l as a part of standard pre-operational protocol. Patients with suspected early postoperative infection complications or fever were excluded from the population. A comparative analysis of the relationship between WBC count and overall survival of at least 24 months after the operation was evaluated using statistical methods. Finally, ROC (Receiver Operating Characteristic) analysis was performed in order to estimate the optimal cut-off value for WBC count that would identify patients who will survive for at least 24 months after the operation.
Results
In the fi ve-year period, a total of 51 patients underwent radical surgery. The population included 36 men and 15 women, the average age being 65 years. In order to prevent possible interference of WBC and CRP levels with decompensated chronic co-morbidities, only patients with the maximum of ASA II risk score and stable chronic disease were included. Patients with ASA III or IV were excluded from this study. According to available documentation 31 patients were subject to chronic hypertensia treatment in mono-or combined therapeutic setting. 14 patients were diagnosed with diabetes mellitus, 4 out of which were treated with combined therapy and 10 treated with peroral antidiabetics (PAD). 19 patients had chronic obstructive bronchopulmonary disease (COPD) in their history. 6 patients reported long-term use of inhalation corticosteroids discontinued 1 day before the surgery at the latest. The distribution of co-morbidities in the patient population was heterogenous with none being prevalent in any of the groups. None of the patients were treated with nonsteroidal anti-infl ammatory drugs (NSAIDs) for longer periods of time that would interfere with WBC and CRP levels. However, occasional use could not be fully excluded. From the aetiology point of view, the most frequent malignancy, as per defi nitive histology, was adenocarcinoma with 56.6%, followed by squamous-cell carcinoma with 35.7%, while only 7.5% of cases represented another type of malignant tumour. After histopatho-logical processing, all T sub-groups, defi ned by the 7th edition of TNM classifi cation were represented in the population (T1 -32.1 %, T2 -58.5 %, T3 -5.7 %, T4 -3.7 %). According to the evaluation of the degree of spreading to lymph nodes, the population was distributed in the N categories as follows: N0 -56.6 %, N1 -13.2 %, N2 -30.2 %. Based on the above, the patients were divided into groups and the overall survival (OS) was evaluated according to the T and the N categories in one-to three-year intervals (annually). Irrespective of the T and the N categories, the overall survival of the whole population in the given interval was as follows: 1-year survival -85.7 %, 2-year survival -70.0 %, 3-year survival -57.8 %. The median overall survival for individual T categories was 35.9 months for T2 tumours and 6.7 months for T3 and T4 tumours of the left upper lobe. No median OS was established for the T1 category as the patients were alive even after three years, as was also the case of patients who had no lymph node involvement (N0). Thus, the results of these groups were censored. As was expected, the OS results were worse in the N1 category -25.4 months and the N2 category -24.3 months. Subsequently, the initial WBC count (drawn on the 3rd day after the operation) of patients surviving at least 24 months after the operation was analysed (Tab. 1). The result of the calculated initial value, 10,00x10 9 in peripheral blood, correlates with the upper limit of the normal range of WBC count. The ROC analysis has shown a total area under the curve (AUC) of 0.67. Based on these fi ndings, the WBC count established 3 days after the operation allows, with 80 % sensitivity and 57.7 % specifi city, to classify patients into groups according to the 24-month overall survival (p = 0.039). The positive predictive value is 64.5 % and the negative predictive value is 75.0 % (Tab. 2).
Discussion
Using infl ammatory markers as a prognostic indicator of cancer recurrence is based on Rudolf Virchow's initial theories about the relationship between chronic infl ammation and the development of malignity. Recent studies have shown that there is a relationship between preoperative CRP level, the ratio of neutrophils and lymphocytes on the one side, and the overall survival and recurrence risk on the other (1, 11) . The interaction of the immune system and malignant cells with developed sterile infl ammation may infl uence angiogenesis and, secondarily, also cell division. Cedres WBC count 3 days after the operation (10 9 /l) n Median OS (95% CI) The study has shown that an elevated CRP level has a negative infl uence on overall survival (6) . Hypothetically, elevated values of infl ammatory markers could be interpreted as a response of the immune system to varying degrees of "aggressive tumour behaviour". WBC count may also be infl uenced by the size of the tumour and the "total tumour mass" (6) . A logical consequence of a radical resection of the tumour should be early normalisation of the postoperative WBC count in the peripheral blood due to the lack of interaction between the immune system and the cancer (7) . By excluding patients with decompensated co-morbidities and with a long history of NSAID usage, we took effort to exclude most possible interfering factors that might have infl uenced the WBC and CRP levels. It has been shown that there is a correlation between a WBC count established on the 72 hours after the operation exceeding 10,00 x 10 9 in peripheral blood and overall survival for 24 months after the operation. The use of postoperative values of infl ammatory markers as a prediction of cancer recurrence could be limited by the infl uence of operative stress and the subsequent response of the immune system that impacts early postoperative values. However, the values of sensitivity and specifi city of the test, as well as the demonstrable statistical signifi cance show that it is possible to predict cancer recurrence. We are aware of the limitations of smaller patient cohorts, however, our fi ndings confi rm a significant relationship between WBC and disease recurrence and provide the rationale for performing large-scale prospective cohort studies.
Conclusion
The immunopathogenesis of infl ammation in a cancer disease and the evaluation of infl ammatory parameters in serum and in peripheral blood appears to be a promising fi eld to search for left upper lobe NSCLC prognostic markers. Our statistical analysis has established a statistically relevant relationship between WBC count in peripheral blood third day after the operation and overall survival for 24 months after the operation where the initial WBC count in peripheral blood exceeded 10,00 x 10 9 . Our fi ndings confi rm the potential of using WBC count to improve current protocols to establish postoperative prognosis for NSCLC of the upper left lobe and highlight the fact that predicting NSCLC recurrence is a multifi eld challenge that requires individual approach to each patient.
